Correlation Between Cyclo Therapeutics and Cyclo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyclo Therapeutics and Cyclo Therapeutics, you can compare the effects of market volatilities on Cyclo Therapeutics and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Cyclo Therapeutics.

Diversification Opportunities for Cyclo Therapeutics and Cyclo Therapeutics

0.48

Correlation Coefficient

Cyclo Therapeutics  Cyclo Therapeutics

Very weak diversification

The 3 months correlation between Cyclo and Cyclo is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Cyclo Therapeutics and Cyclo Therapeutics

Assuming the 90 days horizon Cyclo Therapeutics is expected to under-perform the Cyclo Therapeutics. In addition to that, Cyclo Therapeutics is 2.0 times more volatile than Cyclo Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Cyclo Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest  60.00  in Cyclo Therapeutics on December 28, 2024 and sell it today you would earn a total of  12.00  from holding Cyclo Therapeutics or generate 20.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.33%
Values	Daily Returns

Cyclo Therapeutics  vs.  Cyclo Therapeutics

Cyclo Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cyclo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Cyclo Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Cyclo Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cyclo Therapeutics and Cyclo Therapeutics

The main advantage of trading using opposite Cyclo Therapeutics and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.

The idea behind Cyclo Therapeutics and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.